ESC 365 - Role of galectin-3 and plasma Btype-natriuretic peptide in predicting prognosis in discharged heart failure patients

HFA Premium Access

Role of galectin-3 and plasma Btype-natriuretic peptide in predicting prognosis in discharged heart failure patients

Session: Poster Session 1 - Basic Science: Biomarkers

Topic: Prognosis (using biomarkers)

Speaker: Doctor M. Feola (Mondovi, IT)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Doctor Mauro Feola

Cardiology Department, Mondovi (Italy)

1 presentation

0 follower

13 more presentations in this session

New interesting targets for heart failure therapy in the natriuretic peptide clearance system- could type c natriuretic peptide receptor be as promissing as neprilysin?

Speaker: Doctor K. Kodziszewska (Warsaw, PL)

A preliminary study on carbon-based nanotubes gelatin scaffold for cardiac tissue regeneration

Speaker: Doctor M. Cabiati (Pisa, IT)

Nitric oxide forms a paramagnetic compound with hemoglobin in venous erythrocytes that reflects vascular no bioavailability in vivo and is quantifiable by electron paramagnetic resonance spectroscopy

Speaker: Miss F. Dei Zotti (Brussels, BE)

Circular RNAs in heart failure: identification of MICRA as a novel biomarker of left ventricular dysfunction

Speaker: Ms M. Vausort (Luxembourg, LU)

Circulating miR-122-5p and miR-124a-3p predict outcome after out-of-hospital cardiac arrest. a sub-study of the target temperature management (TTM) trial

Speaker: Doctor A. Salgado Somoza (Luxembourg, LU)

Access the full session

Poster Session 1 - Basic Science: Biomarkers

Speakers: Doctor M. Feola, Doctor K. Kodziszewska, Doctor M. Cabiati, Miss F. Dei Zotti, Ms M. Vausort...

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources